Dimensional Fund Advisors LP Has $135.50 Million Stock Holdings in HealthEquity, Inc. $HQY

Key Points

• Dimensional Fund Advisors LP reduced its holdings in HealthEquity, Inc. by 3.1%, now owning approximately 1.77% of the company, valued at $135.5 million.
• Insider selling included significant transactions by EVP Elimelech Rosner and Director Jon Kessler, with combined sales of nearly $22 million representing large decreases in their ownership stakes.
• Analysts remain optimistic, with multiple firms raising their price targets for HealthEquity, with an average target now at $118.55 and a consensus rating of "Buy".

Dimensional Fund Advisors LP decreased its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 3.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,533,373 shares of the company's stock after selling 49,450 shares during the quarter. Dimensional Fund Advisors LP owned approximately 1.77% of HealthEquity worth $135,496,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Transce3nd LLC acquired a new stake in HealthEquity in the 4th quarter valued at $29,000. Versant Capital Management Inc acquired a new stake in HealthEquity in the 1st quarter valued at $28,000. Larson Financial Group LLC boosted its stake in HealthEquity by 1,366.0% in the 1st quarter. Larson Financial Group LLC now owns 689 shares of the company's stock valued at $61,000 after buying an additional 642 shares in the last quarter. Whipplewood Advisors LLC boosted its stake in HealthEquity by 5,060.0% in the 1st quarter. Whipplewood Advisors LLC now owns 774 shares of the company's stock valued at $68,000 after buying an additional 759 shares in the last quarter. Finally, UMB Bank n.a. boosted its stake in HealthEquity by 104.8% in the 1st quarter. UMB Bank n.a. now owns 848 shares of the company's stock valued at $75,000 after buying an additional 434 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

HealthEquity Trading Down 2.7%

Shares of NASDAQ HQY traded down $2.40 during midday trading on Monday, hitting $87.42. The stock had a trading volume of 905,200 shares, compared to its average volume of 1,008,071. The company's 50-day simple moving average is $96.78 and its 200 day simple moving average is $96.43. The firm has a market cap of $7.56 billion, a P/E ratio of 63.81, a price-to-earnings-growth ratio of 1.39 and a beta of 0.54. HealthEquity, Inc. has a fifty-two week low of $73.84 and a fifty-two week high of $116.65. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, topping analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%.The business had revenue of $330.80 million during the quarter, compared to analysts' expectations of $322.25 million. During the same period in the previous year, the firm earned $0.80 earnings per share. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. Research analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insiders Place Their Bets

In other HealthEquity news, Director Jon Kessler sold 97,767 shares of the stock in a transaction on Friday, June 6th. The shares were sold at an average price of $112.05, for a total value of $10,954,792.35. Following the sale, the director directly owned 75,000 shares in the company, valued at approximately $8,403,750. This trade represents a 56.59% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Elimelech Rosner sold 58,000 shares of the stock in a transaction on Friday, June 6th. The stock was sold at an average price of $112.56, for a total transaction of $6,528,480.00. Following the completion of the sale, the executive vice president owned 75,689 shares in the company, valued at approximately $8,519,553.84. This trade represents a 43.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 291,744 shares of company stock worth $32,705,007. Company insiders own 1.50% of the company's stock.

Analyst Ratings Changes

Several brokerages recently commented on HQY. Barrington Research boosted their price target on HealthEquity from $112.00 to $125.00 and gave the company an "outperform" rating in a research note on Thursday, June 5th. Deutsche Bank Aktiengesellschaft boosted their price target on HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a research note on Thursday, June 5th. Royal Bank Of Canada lifted their price objective on HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a research report on Wednesday, June 4th. Raymond James Financial reiterated a "strong-buy" rating and issued a $120.00 price objective (up previously from $115.00) on shares of HealthEquity in a research report on Tuesday, July 8th. Finally, Bank of America lifted their price objective on HealthEquity from $110.00 to $125.00 and gave the company a "buy" rating in a research report on Wednesday, June 4th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of $118.55.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.